Publications
18
Citations
127
Est. group size
—
Recurring co-author estimate
Active years
31
Publishing since 1995
Susan Tsai's research focuses on the clinical management and treatment of pancreatic cancer, including staging, neoadjuvant (pre-surgery) therapy, radiation planning, and biomarkers that help predict how patients respond to treatment. A recurring theme in recent work is how socioeconomic factors and healthcare access affect who receives comprehensive cancer treatment. This work is relevant to students interested in translational and clinical oncology research, particularly around treatment decision-making and disparities in cancer care.
Publication output has been modest but fairly steady over the past decade, with a noticeable increase in the last three years (2023-2025).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The impact of socioeconomic factors on pancreatic cancer care utilization
PLoS ONE · 2025
- Assessing socioeconomic disparities and the likelihood of multimodal treatment utilization in patients with pancreatic cancer using SEER Medicare data.
Journal of Clinical Oncology · 2025
- Socioeconomic disparities in pancreatic cancer treatment: The role of pre-diagnosis healthcare utilization.
Journal of Clinical Oncology · 2025
- NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics · 2024
- Atm Or Chek2 Alterations as Potential Biomarkers of Improved Outcomes with Irinotecan: Real-World Analysis of Advanced Pancreatic Ductal Adenocarcinoma
SSRN Electronic Journal · 2023
- Su1433 REEXAMINING 8TH EDITION OF AMERICAN JOINT COMMITTEE ON CANCER NODAL STAGING AMONG PATIENTS WITH PANCREATIC CANCER FOLLOWING NEOADJUVANT THERAPY
Gastroenterology · 2023
- Elevated postoperative CA19-9 in patients with pancreatic cancer following the completion of neoadjuvant therapy and surgery - implications for adjuvant therapy and surveillance
HPB · 2021
- Improving Treatment Response Prediction for Chemoradiation Therapy of Pancreatic Cancer Using a Combination of Delta-Radiomics and the Clinical Biomarker CA19-9
Frontiers in Oncology · 2020
- Management of Localized Pancreatic Cancer
2019
- Abstract 3147A: The use of the sTRA glycan for predicting responses to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma
Clinical Research (Excluding Clinical Trials) · 2019
- Resection Versus Chemotherapy for Metastatic Neuroendocrine Tumors of the Pancreas
Difficult decisions in surgery: an evidence-based approach · 2018
- Impact of Nodal Status on Adjuvant Therapy for Patients with Localized Pancreatic Cancer Treated with Neoadjuvant Therapy
Gastroenterology · 2017
- 711 Poor Glycemic Control is Associated With Failure to Complete Neoadjuvant Therapy and Surgery in Patients With Localized Pancreatic Cancer
Gastroenterology · 2016
- Gastroenterology×4
- Journal of Clinical Oncology×2
- International Journal of Radiation Oncology*Biology*Physics×1
- Frontiers in Oncology×1
- PLoS ONE×1
- Mary Dillhoff
Medicine · The Ohio State University
- Omer Saeed
Medicine · Indiana University
- Sean P. Cleary
Medicine · The Ohio State University
- Ashish Manne
Medicine · The Ohio State University
- Ashwini Esnakula
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile